1.74
-0.01(-0.57%)
Currency In USD
| Previous Close | 1.75 |
| Open | 1.73 |
| Day High | 1.76 |
| Day Low | 1.68 |
| 52-Week High | 2.74 |
| 52-Week Low | 0.36 |
| Volume | 3.18M |
| Average Volume | 6.87M |
| Market Cap | 208.71M |
| PE | -1.89 |
| EPS | -0.92 |
| Moving Average 50 Days | 1.15 |
| Moving Average 200 Days | 0.88 |
| Change | -0.01 |
If you invested $1000 in Invivyd, Inc. (IVVD) since IPO date, it would be worth $83.33 as of October 19, 2025 at a share price of $1.74. Whereas If you bought $1000 worth of Invivyd, Inc. (IVVD) shares 3 years ago, it would be worth $533.74 as of October 19, 2025 at a share price of $1.74.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Invivyd Announces U.S. IND Clearance and Alignment with U.S. FDA on Pivotal Clinical Program for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID
GlobeNewswire Inc.
Oct 06, 2025 11:01 AM GMT
The DECLARATION (safety and efficacy vs. placebo) and LIBERTY (exploratory safety head-to-head and combination with mRNA-based COVID vaccination) clinical trials are expected to begin around year-end 2025; top-line data anticipated mid-2026DECLARATIO
Invivyd Appoints Paul B. Bolno, M.D. to Its Board of Directors
GlobeNewswire Inc.
Sep 24, 2025 8:01 PM GMT
NEW HAVEN, Conn., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (NASDAQ: IVVD) today announced the appointment of Paul B. Bolno, M.D., to its Board of Directors and as a member of the Compensation Committee. Dr. Bolno is the President and CEO of
Invivyd Announces Appointment of Kristie Kuhl as Chief Communications Officer
GlobeNewswire Inc.
Sep 17, 2025 11:01 AM GMT
NEW HAVEN, Conn., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced the appointment of Kristie Kuhl as Chief Communications Officer. Ms. Kuhl will lead the Company’s communications and patient advocacy efforts as Inviv